BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

AavantiBio

AavantiBio logo

Publications
1

Technologies

Gene Therapy Startups

AavantiBio is a clinical-stage biopharmaceutical company committed to developing and commercializing novel gene transfer and gene editing therapies for the treatment of rare and ultra-rare genetic diseases. The company is rapidly building a diverse portfolio of gene transfer and gene editing therapies to target debilitating genetic diseases for which the unmet medical need is high for which there are typically no approved therapies treating the underlying disease. AavantiBio is headquartered in Cambridge, MA with additional locations in Gainesville, FL.

Become a Member to view additional information about this company

Posts Mentioning This Company

Biopharma Insights